Guidance
Skip Standards and indicators submenu
Quality standards
Our quality standards set out priority areas for quality improvement. They highlight areas with identified variation in current practice.
View our quality standards
How to use our quality standards
The timeline for developing quality standards
Help us develop quality standards
Selecting and prioritising quality standards topics
About quality standards
Indicators
Our indicators measure outcomes that reflect the quality of care, or processes linked by evidence to improved outcomes.
View list of indicators
Learn about the committee that develops indicators
About indicators
Skip Life sciences submenu
Life Sciences
We offer tailored support to industry during product development. Our expertise can help you build the evidence needed to achieve market access.
View life sciences
Get support from NICE
NICE Advice service
Trusted, unrivalled expertise.
Make an enquiry
Contact us to discuss your requirements.
Innovative Licensing and Access Pathway (ILAP)
Streamlining patient access to safe, financially sustainable and innovative medicines.
Learn how we evaluate technologies
Health technology evaluation and topic selection manuals
Updated manuals for methods, processes and topic selection.
Digital health technologies
Accelerating our efforts to deliver innovation to the health and care system.
Evidence standards framework
Using the best available evidence to develop recommendations that guide decisions in health, public health and social care.
Our guidance programmes
Ensuring new technologies are clinically effective and offer economic value.
Register your product
Non-pharmaceutical
NHS Innovation Service is a clear and simple point of entry for health technologies to access support and national evaluation programmes.
Pharmaceutical
UK PharmaScan is a database of new medicines, indications and formulations in the pharmaceutical pipeline.
Find published and proposed evaluations
Diagnostics
Guidance on measurements and tests used to evaluate a patient's condition.
Medical technologies
Guidance on medical technologies put forward to NICE by manufacturers.
Technology appraisals
Guidance on new and existing medicines and treatments in the NHS.
Highly specialised technologies
Guidance on the use of highly specialised medicines and treatments.
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
Skip About submenu
About
NICE helps practitioners and commissioners get the best care to patients, fast, while ensuring value for the taxpayer.
Explore about
Our programmes
Learn about the information we produce.
Guidance
Advice
Quality standards
Indicators
Digital health
Topic selection
Get involved
Understand how decisions are made:
Attend a committee meeting
Comment on draft guidance:
Guidance in consultation
Be part of a guidance committee:
Join a committee
Help develop our products:
Register as a stakeholder
Putting you at the heart of our work:
Public involvement
What we do
Social care
Life sciences
NICE international
Patient safety
Shared decision making
Into practice
Social care quick guides
Measuring the use of NICE guidance
Resource planner
View all Into practice
Who we are
The board
The NICE strategy 2021 to 2026
Corporate publications
View all Who we are
- Contact us
- Jobs

Antenatal care

NICE guideline
Reference number: NG201
Published: 19 August 2021

Register as a stakeholder

Evidence

Supporting evidence

Surveillance report
2024 exceptional surveillance of antenatal care (NICE guideline NG201)
Evidence review
Evidence reviews – August 2021
A: Information provision (PDF 1.02 MB)

Published:

19 August 2021
B: Approaches to information provision (PDF 827 KB)

Published:

19 August 2021
C: Involving partners (PDF 1.79 MB)

Published:

19 August 2021
D: Peer support (PDF 967 KB)

Published:

19 August 2021
E: Antenatal classes (PDF 806 KB)

Published:

19 August 2021
F: Accessing antenatal care (PDF 396 KB)

Published:

19 August 2021
G: Content of antenatal appointments (PDF 322 KB)

Published:

19 August 2021
H: Timing of first antenatal appointment (PDF 417 KB)

Published:

19 August 2021
I: Number of antenatal appointments (PDF 820 KB)

Published:

19 August 2021
J: Referral and delivery of antenatal care (PDF 1.44 MB)

Published:

19 August 2021
K: Identification of hypertension in pregnancy (PDF 355 KB)

Published:

19 August 2021
L: Identification of breech presentation (PDF 518 KB)

Published:

19 August 2021
M: Management of breech presentation (PDF 2.22 MB)

Published:

19 August 2021
N: Risk factors for venous thromboembolism in pregnancy (PDF 1.35 MB)

Published:

19 August 2021
O: Monitoring fetal growth (PDF 1.04 MB)

Published:

19 August 2021
P: Fetal movement monitoring (PDF 1.09 MB)

Published:

19 August 2021
Q: Routine third trimester ultrasound for fetal growth (PDF 1.14 MB)

Published:

19 August 2021
R: Management of nausea and vomiting in pregnancy (PDF 2.55 MB)

Published:

19 August 2021
S: Management of heartburn in pregnancy (PDF 748 KB)

Published:

19 August 2021
T: Management of symptomatic vaginal discharge in pregnancy (PDF 703 KB)

Published:

19 August 2021
U: Management of pelvic girdle pain in pregnancy (PDF 148.89 MB)

Published:

19 August 2021
V: Management of unexplained vaginal bleeding in pregnancy (PDF 488 KB)

Published:

19 August 2021
W: Maternal sleep position during pregnancy (PDF 817 KB)

Published:

19 August 2021
Other supporting evidence
Supplement 1: Methods (PDF 447 KB)

Published:

19 August 2021
Economic analysis
Supplement 2: Health economics (PDF 313 KB)

Published:

19 August 2021